SPTM: The Valuation Premium Is Hard To Justify

SPTM holds more than 1,500 U.S. stocks, but its top 10 positions account for 36.2% of the portfolio, leaving performance concentrated in mega-cap names. The article argues that the S&P 500's valuation premium to mid-caps is less attractive as large-cap forward earnings growth advantage narrows.

Analysis

The portfolio’s security count may overstate its diversification: a small group of mega-cap stocks can still drive index-level returns, so exposure to SPTM is partly a concentrated growth-and-duration position. If the large-cap earnings-growth edge continues to narrow, the risk is not just weaker relative earnings contribution; a valuation premium could also contract, compounding relative underperformance. Conversely, a premium can persist if those companies continue to deliver more dependable earnings or if risk aversion reinforces demand for perceived quality.

The key near-term test is whether earnings revisions broaden beyond mega-cap technology. Over the next 1–3 months, watch results and guidance for evidence of improving mid-cap earnings breadth, alongside interest-rate moves that affect long-duration equity valuations. Over 6–18 months, sustained breadth could support a durable rotation; one weak quarter or a temporary valuation gap alone would not establish that trend. The article’s valuation and growth comparisons should be independently checked against current estimates and consistent periods before sizing a trade.

Key Decisions for Investors

• Avoid treating SPTM as an equal-weighted or fully diversified U.S. equity allocation; stress-test portfolio exposure to its largest constituents and to growth-factor drawdowns.
• For a relative-value watchlist, consider long RSP (equal-weight S&P 500) versus short SPTM only if earnings revisions broaden and the relative performance trend confirms. This expresses a concentration/breadth view, not a guaranteed mid-cap catch-up trade; size modestly given sector and factor differences.
• Do not initiate solely on the valuation-premium argument. Verify current valuation measures, forward earnings revisions by market-cap cohort, and the ETF’s latest holdings; missing or stale inputs could materially change the risk/reward.
• Falsify the rotation thesis if mega-cap earnings revisions re-accelerate relative to the rest of the market and SPTM resumes sustained relative strength. Reassess the trade if breadth deteriorates or rate moves disproportionately pressure equal-weight exposures.